According to GlobalData, NEUROTUBE is one of 18 product lines sold in the US peripheral nerve repair market; these product lines are sold by 7 different manufacturers. The price of the NEUROTUBE device can be viewed in GlobalData’s micro pricing report and can be retrieved according to purchase date, facility type, bed size, and geographical region. Buy the report here.
The selling price or list price of a medical device is driven by numerous factors, such as therapy area and complexity of procedure, level of reimbursement, development costs, the number of competing manufacturers, product life cycle, and whether there have been any recent new technology or product launches.
In addition, the final selling pricing of medical devices is also impacted by the discounting policy of the manufacturer. Companies such as Synovis Life Technologies apply discounts for their devices based on their internal business strategy, inventory control, and monthly or quarterly sales targets. In addition, sale location can also affect the final selling price of a device, both in terms of geographical region and facility type. Prices for the same medical device often vary in hospitals and health systems versus outside of hospital facilities, for example if high volume healthcare institutions can negotiate discounts or rebates based on large purchase sizes.
Synovis Life Technologies overview
Synovis Life Technologies Inc, is a medical device company that design, develop and markets biomaterial devices for repairing soft tissue and preventing air, blood, and other fluid leaks. The company is headquartered in Saint Paul, Minnesota, the US.
For a complete picture of NEUROTUBE, Peripheral Nerve Repair pricing in the US, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.